IDH2 and glioma: Some studies have shown that nestin is a negative prognostic factor in terms of survival, while other studies, including ours, have not identified any statistically significant correlation between its reaction and the survival of patients with grade 4 glioma (either mutant IDH or wildtype) [34,35,36,37].